This upcoming July is healthy vision month, a time to remember the importance of making vision and eye health a priority. It's also a time to think about the approximately 12 million people, 40 and over in the United States, that have a vision impairment. Vision can be something that many of us take for … Continue reading CIRM funded trial for AMD shows promising results
retinal pigment epithelium
CIRM-funded research aims to create a platform to test therapies for AMD
People with late stage age-related macular degeneration lose their central vision. So an image like the one on the left might appear to them as shown on the right. Credit: University of California - Santa Barbara Our vision is one of the most important senses that we use in our everyday lives. Whether its to … Continue reading CIRM-funded research aims to create a platform to test therapies for AMD
Encouraging news about CIRM-funded clinical trial targeting vision loss
Dry age-related macular degeneration (AMD) is the leading cause of vision loss in the U.S. By 2020 it’s estimated that as many as three million Americans will be affected by the disease. Right now, there is no effective therapy. But that could change. A new CIRM-funded clinical trial is showing promise in helping people battling … Continue reading Encouraging news about CIRM-funded clinical trial targeting vision loss
The Stem Cellar 